Product Information
BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0423 per EA under NDC 00904689961. Its NADAC has been published 349 times since Oct 23, 2019.
The Low Outlier badge above means this manufacturer's average price in the Buspirone hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904689961
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078888On Market Since
5/3/2014
Price Statistics
The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 349 times since Oct 23, 2019, and over the history we have for it it has declined 41.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0719 (Nov 13, 2019) |
| All-time low | $0.0359 (Nov 20, 2024) |
| 52-week high | $0.0485 |
| 52-week low | $0.0423 |
| Median price | $0.0501 |
| Average price | $0.0520 |
| Largest weekly change | -29.4% (Nov 20, 2024) |
| Weeks tracked | 349 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0423 per EA (NDC 00904689961), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 41.2%. It has been tracked across 349 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?
Since Oct 23, 2019, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0359 (Nov 20, 2024) to a high of $0.0719 (Nov 13, 2019), with a median of $0.0501 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 15 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 15 MG TABLET?
BUSPIRONE HCL 15 MG TABLET (NDC 00904689961) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification